Surplus Equipment from Intellia Therapeutics Resulting from Facility Consolidation, a Leading Clinical Stage Genome Editing Company, Cambridge, MA
Featuring Late-Model Mass Spectrometry, Chromatography, Flow Cytometry, Cell Sorting & Automated Liquid Handling Platforms from SCIEX, Waters, Bruker, Cytiva, BD Biosciences, Agilent Technologies, TTP Labtech & Other Leading OEMs!